These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 29315

  • 21. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
    Diamond BI, Pasinetti G, Hitri A, Borison RL.
    Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
    Ambani LM, Van Woert MH, Bowers MB.
    Arch Neurol; 1973 Dec; 29(6):444-6. PubMed ID: 4759422
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV, Gaonkar RK, Jadhav SA, Thorat VM, Jadhav JH, Balsara JJ.
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [Abstract] [Full Text] [Related]

  • 27. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J, Knoll B, Knoll J.
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
    [Abstract] [Full Text] [Related]

  • 28. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB.
    Farmakol Toksikol; 1973 Dec; 26(4):481-9. PubMed ID: 4151298
    [No Abstract] [Full Text] [Related]

  • 29. Neuroleptics attentuate stereotyped behavior induced by beta-phenylethylamine in rats.
    Moja EA, Stoff DM, Gillin JC, Wyatt RJ.
    Biol Psychiatry; 1978 Apr; 13(2):291-5. PubMed ID: 566570
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Proceedings: Mechanisms involved in the effect of apomorphine on the extrapyramidal system of the rat.
    Loew DM, Vigouret JM.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Aug 15; 287 Suppl():R10. PubMed ID: 1170505
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S.
    Zasshi Tokyo Ika Daigaku; 1969 Jan 15; 27(1):1-22. PubMed ID: 4978901
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C, Merlis S.
    Am J Psychiatry; 1967 Jan 15; 123(7):886-9. PubMed ID: 6016862
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.